Research and Development

Showing 15 posts of 9618 posts found.

ABPI

UK ‘lacks the skills’ for future drug development, ABPI warns

November 11, 2015 Business Services, Research and Development ABPI, Jobs, careers, recruitment, skills gap

A shortage of skilled professionals threatens to undermine research and development of new medicines in the UK and prevent growth …
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015 Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

Lilly/Incyte RA drug bests Humira in Phase III trial

November 10, 2015 Research and Development Humira, baricitinib, lilly, phase III, rheumatoid arthritis

Eli Lilly says its investigational therapy baricitinib outperformed AbbVie’s Humira after 12 weeks in a late-stage study of people with …
ABPI

ABPI welcomes science budget inquiry findings

November 10, 2015 Manufacturing and Production, Research and Development ABPI, Comprehensive Spending Review

The UK pharma trade body, the ABPI, has welcomed the findings of the Science and Technology Committee’s inquiry into the …
Westminster

All Party Parliamentary Group for Life Sciences CSR letter to the Chancellor, Business Secretary and Science Ministers

November 10, 2015 Manufacturing and Production, Research and Development Chancellor, Comprehensive Spending Review, George Osborne

Dear Mr Osborne,Ahead of the forthcoming Comprehensive Spending Review I am sure you will have received many letters from across …
Janssen image

Janssen buys licence to diabetes and obesity drugs from Hanmi

November 10, 2015 Manufacturing and Production, Research and Development Janssen, diabetes, hanmi

Janssen could spend up to a billion dollars to buy for novel clinical stage biologics to treat diabetes and obesity. …
flu vaccine

Sanofi Pasteur ‘actively exploring’ universal flu vaccine

November 10, 2015 Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine

Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …

Health minister criticised for blocking Off-Patent Drugs Bill debate

November 9, 2015 Research and Development, Sales and Marketing Alistair Burt, Breast Cancer Now, MS Society, Off-Patent Drugs Bill

A Parliamentary Bill backing the wider use of off-patent drugs has been kicked into the long grass after the Government …
clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015 Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …

UK doctors embracing technology, but not for their patients, survey reveals

November 6, 2015 Medical Communications, Research and Development

A global online survey of doctors released by market research agency Cello Health Insight has indicated that although UK doctors …
Sanofi logo

Sanofi buys in new diabetes drug

November 6, 2015 Medical Communications, Research and Development, Sales and Marketing Lexicon Pharma, SGLT2, SGLT2 inhibitors, Sanofi, sotagliflozin

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …
nsclc_merck_pfizer

Merck and Pfizer begin new Phase III avelumab trial in lung cancer

November 5, 2015 Medical Communications, Research and Development Merck, Pfizer, avelumab, lung cancer, non-small cell lung cancer

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015 Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …
President Obama

Obama government launches drug price crackdown

November 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access

President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …
The Gateway to Local Adoption Series

Latest content